VIR Earnings

Quarterly EPS
$-1.56
Q3 2024
$-0.76
Q4 2024
$-0.88
Q1 2025
$-0.80
Q2 2025
$-1.17
Q3 2025
$-0.31
Q4 2025
$-0.85
Q1 2026
$0.48
Q2 2026
Latest Revenue238.9M
Latest Net Income80.1M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.48238.9M80.1M+19,582.5%+160.0%
Q1 2026-$0.85-29000-125695000-101.0%+3.4%
Q4 2025-$0.3164.1M-42923000+417.8%+59.2%
Q3 2025-$1.17240.0K-163141000-89.9%+25.0%
Q2 2025-$0.801.2M-110958000-60.5%+21.6%
Q1 2025-$0.883.0M-120965000-94.6%-83.3%
Q4 2024-$0.7612.4M-104589000-26.3%+11.6%
Q3 2024-$1.562.4M-213717000-9.8%-27.9%
Q2 2024-$1.023.1M-138378000
Q1 2024-$0.4856.4M-65276000
Q4 2023-$0.8616.8M-115973000
Q3 2023-$1.222.6M-163413000
Vir Biotechnology (VIR) — Earnings